Resources

Publications

12/07/2021
- Oncology
Loss of ASXL1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
The Frequency and Somatic Mutation Landscape of Fibroblast Growth Factor Receptor (FGFR) Alterations in Breast Cancer
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Genomic Landscape of HER2-Negative Advanced or Metastatic Breast Cancer with PIK3CA Gain-of-Function Mutations
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Mouse-INtraDuctal (MIND): An In Vivo Model for Studying the Underlying Mechanisms of DCIS Malignancy
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
A Platform of CDK4/6 Inhibitor-Resistant Patient-Derived Breast Cancer Organoids Illuminates Mechanisms of Resistance and Therapeutic Vulnerabilities
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Preclinical Activity of KB-0742, an Oral, Highly Selective, CDK9 Inhibitor, in Cell Lines and in MYC-High Expressing, Patient-Derived Models of Multiple Breast Cancer Subtypes
San Antonio Breast Cancer Symposium
12/07/2021
- Oncology
Comprehensive Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma (ILC): Using Real-World Data to Describe this Unique Clinical Entity
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
The Genomic and Transcriptomic Landscape of PIK3R1-Mutated Breast Cancers
San Antonio Breast Cancer Symposium 2021
12/07/2021
- Oncology
Characterization of the Immune Landscape of Primary vs Metastatic Breast Cancer in a Real-World Data Cohort
San Antonio Breast Cancer Symposium 2021
11/19/2021
- Oncology
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms
The American Journal of Surgical Pathology

47 48 49